21 August 2019
XARELTO (rivaroxaban) Helps Protect Pediatric Patients from Blood Clots in Late-Breaking Phase 3 EINSTEIN-Jr Study
News
09 August 2019
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis
02 August 2019
The National Institute for Health and Care Excellence (NICE) is recommending Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease
01 August 2019
The UK Forum on Haemoglobin disorders (UKFHD) 49th Academic Meeting